Augmedix logo

AugmedixNASDAQ: AUGX

Profile

Sector:

Healthcare

Country:

United States

IPO:

31 March 2021

Next earnings report:

06 November 2024

Last dividends:

N/A

Next dividends:

N/A
$115.72 M
-60%vs. 3y high
46%vs. sector
-vs. 3y high
-vs. sector
-97%vs. 3y high
93%vs. sector
-70%vs. 3y high
39%vs. sector

Price

regular market | Wed, 02 Oct 2024 13:30:00 GMT
$2.35(0.00%)

Dividend

No data over the past 3 years
$13.66 M$12.75 M
$13.66 M-$8.45 M

Analysts recommendations

Institutional Ownership

Included in screeners

No data

AUGX Latest News

Commure Completes Merger with Augmedix
globenewswire.com02 October 2024 Sentiment: POSITIVE

SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Commure, a healthcare technology company, announced today that it has completed the acquisition of Augmedix. Augmedix will now operate as a wholly-owned subsidiary of Commure.

7 AI Penny Stocks to Watch in October
247wallst.com27 September 2024 Sentiment: POSITIVE

If you're considering an investment in penny stocks, you should consider looking into those in markets with a lot of room for innovation.

STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Merger and Looming Vote on September 27, 2024, of Augmedix, Inc. - AUGX
prnewswire.com06 September 2024 Sentiment: NEUTRAL

NEW YORK , Sept. 6, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report.

Augmedix, Inc. (AUGX) Reports Q2 Loss, Lags Revenue Estimates
zacks.com12 August 2024 Sentiment: NEGATIVE

Augmedix, Inc. (AUGX) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.12 per share a year ago.

Augmedix Delivers 27% Revenue Growth for Second Quarter of 2024
globenewswire.com12 August 2024 Sentiment: POSITIVE

SAN FRANCISCO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three months ended June 30, 2024.

STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Augmedix, Inc. – AUGX
globenewswire.com30 July 2024 Sentiment: NEUTRAL

NEW YORK, July 30, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Augmedix , Inc . ( Nasdaq : AUGX ) , relating to its proposed merger with Commure, Inc. Under the terms of the agreement, Augmedix stock will be converted into the right to receive $2.35 in cash per share.

Why Is Augmedix (AUGX) Stock Up 150% Today?
investorplace.com19 July 2024 Sentiment: POSITIVE

Amid a sea of red in today's stock market, AI medical documentation and data solutions company Augmedix (NASDAQ: AUGX ) is certainly among the standout winners. Shares of AUGX stock have skyrocketed 150% in afternoon trading on a rather substantial announcement.

Shareholder Alert: Ademi LLP investigates whether Augmedix, Inc. has obtained a Fair Price for its Public Shareholders
prnewswire.com19 July 2024 Sentiment: NEGATIVE

MILWAUKEE , July 19, 2024 /PRNewswire/ -- Ademi LLP is investigating Augmedix (Nasdaq: AUGX) for possible breaches of fiduciary duty and other violations of law in its transaction with Commure. Click here to learn how to join our investigation https://www.ademilaw.com/case/augmedix-inc or call Guri Ademi toll-free at 866-264-3995.

Augmedix to Join Forces with Commure
globenewswire.com19 July 2024 Sentiment: POSITIVE

Combination to Strengthen Ability to Deliver Frontier Ambient AI Solutions; Augmedix Stockholders to Receive $2.35 Per Share in All-Cash Acquisition by Commure Combination to Strengthen Ability to Deliver Frontier Ambient AI Solutions; Augmedix Stockholders to Receive $2.35 Per Share in All-Cash Acquisition by Commure

Why Is Augmedix (AUGX) Stock Down 41% Today?
InvestorPlace14 May 2024 Sentiment: NEGATIVE

Augmedix stock is declining on Tuesday following the release of its Q1 2024 earnings report, with disappointing news coming from its outlook update for investors.

  • 1(current)
  • 2
  • 3

What type of business is Augmedix?

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was formerly known as Malo Holdings Corporation and changed its name to Augmedix, Inc. in October 2020. The company was founded in 2013 and is headquartered in San Francisco, California.

What sector is Augmedix in?

Augmedix is in the Healthcare sector

What industry is Augmedix in?

Augmedix is in the Health Information Services industry

What country is Augmedix from?

Augmedix is headquartered in United States

When did Augmedix go public?

Augmedix initial public offering (IPO) was on 31 March 2021

What is Augmedix website?

https://www.augmedix.com

Is Augmedix in the S&P 500?

No, Augmedix is not included in the S&P 500 index

Is Augmedix in the NASDAQ 100?

No, Augmedix is not included in the NASDAQ 100 index

Is Augmedix in the Dow Jones?

No, Augmedix is not included in the Dow Jones index

When was Augmedix the previous earnings report?

No data

When does Augmedix earnings report?

The next expected earnings date for Augmedix is 06 November 2024